Rachel Williams
Biography
Rachel Williams is counsel in Weil’s Antitrust practice. She focuses on civil antitrust, class action, and other complex litigation, as well as transactional regulatory clearance, antitrust counseling, and government investigations.
Rachel also has an active pro bono practice, which of late has included work on behalf of the Innocence Project and Legal Services of New York.
Rachel received her B.S. in Business Administration and her M.S. in Finance from University of Florida. She earned her J.D. from University of Florida Fredric G. Levin College of Law. During law school, she served as a legal intern in the Enforcement Division at the Securities and Exchange Commission.
Litigation and Dispute Resolution – Representative Matters
- Pospisil et al. v. ATP Tour, Inc. et al. (S.D.N.Y.): Representing a plaintiff class of professional tennis players in an antitrust action against the Grand Slams and the men’s and women’s professional tennis tours.
- In re: GoodRx and Pharmacy Benefit Manager Antitrust Litig. (No. II) (D.R.I.): Representing GoodRx in a class action alleging that GoodRx conspired with Pharmacy Benefit Managers regarding reimbursement rates to independent pharmacies via GoodRx’s integrated savings program.
- Calhoun v. California Interscholastic Federation et al. (N.D. Cal.): Obtained dismissal of all claims for broadcaster and streamer in putative antitrust class action seeking compensation for high school athletes for the use of their name, images, and likenesses in sports broadcasts and accounts.
- Regeneron Pharms., Inc. v. Amgen Inc. (D. Del.): Secured a $407 million jury verdict for Regeneron in an antitrust suit challenging a cross-therapeutic bundling scheme that sought to exclude Regeneron’s cardiovascular medication Praluent® from the market. Following a seven-day trial, secured a victory on 10 of 11 counts and damages for Regeneron.
- Giordano et al. v. Saks & Co. et al. (E.D.N.Y.): Secured a motion to dismiss, which was affirmed by the Second Circuit, for Saks Fifth Avenue and co-defendant luxury retail brands in an alleged “no poach” antitrust class action in which Plaintiffs claimed Saks orchestrated “no hire” agreements with each luxury brand.
- FTC v. Meta Platforms, Inc. et al. (N.D. Cal.): Successfully represented Meta with co-counsel in the federal proceeding relating to its proposed acquisition of virtual reality studio, Within Unlimited, best known for its fitness app Supernatural. Following a seven-day bench trial, the FTC’s request for a preliminary injunction to block the proposed acquisition was denied and the transaction closed.
- FashionPass, Inc. v. Rent the Runway, Inc. et al. (C.D. Cal.): Represented Rent the Runway (RTR) against allegations by FashionPass that RTR’s contracts with fashion designers allegedly harmed competition and tortiously interfered with business opportunities. After obtaining a dismissal of the initial complaint, the matter was successfully resolved.
- Regeneron Pharms., Inc. v. Novartis Pharma AG (N.D.N.Y.): Represented Regeneron in connection with monopolization and other claims against Novartis relating to actions taken to prevent competition from Regeneron’s PFS version of Eylea.
- Davitashvili et al. v Grubhub Inc. et al. (S.D.N.Y.): Representing Grubhub in a purported antitrust class action brought against Grubhub and other meal delivery services alleging that defendants use their dominant market positions to force restaurants to charge elevated prices to all of their customers through the use of certain contract restrictions between defendants and the restaurants that utilize their platforms.
- Duke University et al. v. Akorn, Inc. et al. (D.N.J.): Represented Allergan in a successful defense against antitrust counterclaims brought by Akorn related to the eyelash hair-growth drug product LATISSE®, including the allegation that this case and prior patent infringement lawsuits were “sham” litigations aimed a harming Akorn, and that these cases hurt competition in the broader market for generic competition with LATISSE®.
- In re Liquid Aluminum Sulfate Antitrust Litig. (D.N.J.): Represented a global chemicals manufacturer in connection with a Department of Justice criminal antitrust investigation regarding alleged price fixing in the market for liquid aluminum sulfate, a key water treatment chemical, as well as in related class action litigation and state false claims act cases.
- Confidential Arbitration: Represented a major e-commerce company in a contract dispute relating to a multi-year operating agreement with a former business partner. Following a five-day evidentiary trial and post-trial briefing, Weil secured a complete victory and significant damages for the client.
Transactions – Representative Matters
- Represented Meta Platforms (f/k/a Facebook) in its acquisition of Within, the immersive media startup behind the VR fitness service Supernatural.
- Represented Meta Platforms (f/k/a Facebook) in its $1 billion acquisition of Kustomer, a customer relationship management (CRM) company.
- Represented MGM Resorts International in its $1.625 billion acquisition of the operations of The Cosmopolitan of Las Vegas.
- Represented Magellan Health in the $850 million sale of its Magellan Complete Care business to Molina Healthcare, Inc.
Firm News & Announcements, Speaking Engagements, Guides and Resources, Latest Thinking, Awards and Recognition
Firm News & Announcements
- Weil Advises MarketAxess in its $6B Acquisition by Intercontinental Exchange Deal Brief — July 30, 2026
- Weil Helps Regeneron Secure Landmark $407M Antitrust Jury Trial Victory in Competitor Dispute Regarding Biotech Innovation Deal Brief — May 15, 2025
- Weil Secures Second Circuit Victory for Saks Fifth Avenue in “No Hire” Antitrust Class Action Litigation Win — March 14, 2025
Latest Thinking
- A Million Reasons to Report: The DOJ’s Antitrust Whistleblower Rewards Program in Action Blog Post — WorthWeil Antitrust Blog — By Adam C. Hemlock, Rachel Williams and Arlinda Shehu — February 11, 2026
- Global Antitrust Trends for 2024: Successfully Navigating the Global Antitrust Landscape Blog Post — WorthWeil Antitrust Blog — By Brianne Kucerik, Michael Moiseyev and Rachel Williams — January 31, 2024